A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality - the CopD-study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality - the CopD-study. / Durup, Darshana; Jørgensen, Henrik Løvendahl; Christensen, Jane; Tjønneland, Anne; Olsen, Anja; Halkjær, Jytte; Lind, Bent; Heegaard, Anne-Marie; Schwarz, Peter.

In: The Journal of clinical endocrinology and metabolism, Vol. 100, No. 6, jc20144551, 24.02.2015, p. 2339-46.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Durup, D, Jørgensen, HL, Christensen, J, Tjønneland, A, Olsen, A, Halkjær, J, Lind, B, Heegaard, A-M & Schwarz, P 2015, 'A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality - the CopD-study', The Journal of clinical endocrinology and metabolism, vol. 100, no. 6, jc20144551, pp. 2339-46. https://doi.org/10.1210/jc.2014-4551

APA

Durup, D., Jørgensen, H. L., Christensen, J., Tjønneland, A., Olsen, A., Halkjær, J., Lind, B., Heegaard, A-M., & Schwarz, P. (2015). A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality - the CopD-study. The Journal of clinical endocrinology and metabolism, 100(6), 2339-46. [jc20144551]. https://doi.org/10.1210/jc.2014-4551

Vancouver

Durup D, Jørgensen HL, Christensen J, Tjønneland A, Olsen A, Halkjær J et al. A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality - the CopD-study. The Journal of clinical endocrinology and metabolism. 2015 Feb 24;100(6):2339-46. jc20144551. https://doi.org/10.1210/jc.2014-4551

Author

Durup, Darshana ; Jørgensen, Henrik Løvendahl ; Christensen, Jane ; Tjønneland, Anne ; Olsen, Anja ; Halkjær, Jytte ; Lind, Bent ; Heegaard, Anne-Marie ; Schwarz, Peter. / A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality - the CopD-study. In: The Journal of clinical endocrinology and metabolism. 2015 ; Vol. 100, No. 6. pp. 2339-46.

Bibtex

@article{43c7504d6c7e4b42a6766d201b60f18e,
title = "A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality - the CopD-study",
abstract = "CONTEXT: Cardiovascular disease is the major cause of death in the Western World, but the association between 25-hydroxyvitamin D levels and the risk of cardiovascular disease mortality remains unclear OBJECTIVE: To determine the association between cardiovascular, stroke and acute myocardial infarct mortality and serum levels of 25(OH)D DESIGN: Observational cohort study, the CopD Study, data from a single laboratory center in Copenhagen, Denmark. Follow-up 2004 to 2011 SETTING: Serum 25(OH)D was analyzed from 247,574 subjects from the Copenhagen general practice sector PARTICIPANTS: Examination of the association 25-hydroxyvitamin D levels and mortality from cardiovascular disease, stroke and acute myocardial infarct among 161,428 women and 86,146 men MAIN OUTCOME MEASURES: Multivariate Cox regression analysis was used to compute hazard ratios for cardiovascular, stroke and acute myocardial infarct mortality.RESULTS: Out of 247,574 a total of 16.645 subjects died in the ensuing 0-7 years. 5,454 died from cardiovascular disease including 1,574 from stroke and 702 acute myocardial infarct. 25-hydroxyvitamin D level of 70 nmol/L was associated with the lowest cardiovascular disease mortality risk. Compared to that level the hazard ratio for cardiovascular disease mortality was 2.0(95% CI 1.8-2.1) at the lower extreme (∼12.5 nmol/L) with higher risk for men 2.5(95% CI 2.2-2.9), than for women 1.7(95% CI 1.5-1.9). At the higher extreme (∼125 nmol/L), the hazard ratio of cardiovascular disease mortality was 1.3(95% CI 1.2-1.4), with similar risk among men and women. Results were similar for stroke and acute myocardial subgroups CONCLUSIONS: In this large observational study low and high levels of 25-hydroxyvitamin D were associated with cardiovascular disease, stroke and acute myocardial mortality in a non-linear, reverse J-shaped manner, with highest risk at lower levels. Whether this was a causal or associational finding cannot be determined from our data. There is a need for randomized clinical trials which include information on the effects of 25-hydroxyvitamin D levels above 100 nmol/L.",
author = "Darshana Durup and J{\o}rgensen, {Henrik L{\o}vendahl} and Jane Christensen and Anne Tj{\o}nneland and Anja Olsen and Jytte Halkj{\ae}r and Bent Lind and Anne-Marie Heegaard and Peter Schwarz",
year = "2015",
month = feb,
day = "24",
doi = "10.1210/jc.2014-4551",
language = "English",
volume = "100",
pages = "2339--46",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "6",

}

RIS

TY - JOUR

T1 - A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality - the CopD-study

AU - Durup, Darshana

AU - Jørgensen, Henrik Løvendahl

AU - Christensen, Jane

AU - Tjønneland, Anne

AU - Olsen, Anja

AU - Halkjær, Jytte

AU - Lind, Bent

AU - Heegaard, Anne-Marie

AU - Schwarz, Peter

PY - 2015/2/24

Y1 - 2015/2/24

N2 - CONTEXT: Cardiovascular disease is the major cause of death in the Western World, but the association between 25-hydroxyvitamin D levels and the risk of cardiovascular disease mortality remains unclear OBJECTIVE: To determine the association between cardiovascular, stroke and acute myocardial infarct mortality and serum levels of 25(OH)D DESIGN: Observational cohort study, the CopD Study, data from a single laboratory center in Copenhagen, Denmark. Follow-up 2004 to 2011 SETTING: Serum 25(OH)D was analyzed from 247,574 subjects from the Copenhagen general practice sector PARTICIPANTS: Examination of the association 25-hydroxyvitamin D levels and mortality from cardiovascular disease, stroke and acute myocardial infarct among 161,428 women and 86,146 men MAIN OUTCOME MEASURES: Multivariate Cox regression analysis was used to compute hazard ratios for cardiovascular, stroke and acute myocardial infarct mortality.RESULTS: Out of 247,574 a total of 16.645 subjects died in the ensuing 0-7 years. 5,454 died from cardiovascular disease including 1,574 from stroke and 702 acute myocardial infarct. 25-hydroxyvitamin D level of 70 nmol/L was associated with the lowest cardiovascular disease mortality risk. Compared to that level the hazard ratio for cardiovascular disease mortality was 2.0(95% CI 1.8-2.1) at the lower extreme (∼12.5 nmol/L) with higher risk for men 2.5(95% CI 2.2-2.9), than for women 1.7(95% CI 1.5-1.9). At the higher extreme (∼125 nmol/L), the hazard ratio of cardiovascular disease mortality was 1.3(95% CI 1.2-1.4), with similar risk among men and women. Results were similar for stroke and acute myocardial subgroups CONCLUSIONS: In this large observational study low and high levels of 25-hydroxyvitamin D were associated with cardiovascular disease, stroke and acute myocardial mortality in a non-linear, reverse J-shaped manner, with highest risk at lower levels. Whether this was a causal or associational finding cannot be determined from our data. There is a need for randomized clinical trials which include information on the effects of 25-hydroxyvitamin D levels above 100 nmol/L.

AB - CONTEXT: Cardiovascular disease is the major cause of death in the Western World, but the association between 25-hydroxyvitamin D levels and the risk of cardiovascular disease mortality remains unclear OBJECTIVE: To determine the association between cardiovascular, stroke and acute myocardial infarct mortality and serum levels of 25(OH)D DESIGN: Observational cohort study, the CopD Study, data from a single laboratory center in Copenhagen, Denmark. Follow-up 2004 to 2011 SETTING: Serum 25(OH)D was analyzed from 247,574 subjects from the Copenhagen general practice sector PARTICIPANTS: Examination of the association 25-hydroxyvitamin D levels and mortality from cardiovascular disease, stroke and acute myocardial infarct among 161,428 women and 86,146 men MAIN OUTCOME MEASURES: Multivariate Cox regression analysis was used to compute hazard ratios for cardiovascular, stroke and acute myocardial infarct mortality.RESULTS: Out of 247,574 a total of 16.645 subjects died in the ensuing 0-7 years. 5,454 died from cardiovascular disease including 1,574 from stroke and 702 acute myocardial infarct. 25-hydroxyvitamin D level of 70 nmol/L was associated with the lowest cardiovascular disease mortality risk. Compared to that level the hazard ratio for cardiovascular disease mortality was 2.0(95% CI 1.8-2.1) at the lower extreme (∼12.5 nmol/L) with higher risk for men 2.5(95% CI 2.2-2.9), than for women 1.7(95% CI 1.5-1.9). At the higher extreme (∼125 nmol/L), the hazard ratio of cardiovascular disease mortality was 1.3(95% CI 1.2-1.4), with similar risk among men and women. Results were similar for stroke and acute myocardial subgroups CONCLUSIONS: In this large observational study low and high levels of 25-hydroxyvitamin D were associated with cardiovascular disease, stroke and acute myocardial mortality in a non-linear, reverse J-shaped manner, with highest risk at lower levels. Whether this was a causal or associational finding cannot be determined from our data. There is a need for randomized clinical trials which include information on the effects of 25-hydroxyvitamin D levels above 100 nmol/L.

U2 - 10.1210/jc.2014-4551

DO - 10.1210/jc.2014-4551

M3 - Journal article

C2 - 25710567

VL - 100

SP - 2339

EP - 2346

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

M1 - jc20144551

ER -

ID: 132961268